Pulmonary Fibrosis Foundation Launches Partnership With Inspire Online Support ... - MarketWatch (press release)
Pulmonary Fibrosis Foundation Launches Partnership With Inspire Online Support ... MarketWatch (press release) About the Pulmonary Fibrosis FoundationThe mission of the Pulmonary Fibrosis Foundation (PFF) is to help find a cure for idiopathic pulmonary fibrosis (IPF), advocate for the pulmonary fibrosis community, promote disease awareness, and provide a ...
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive ... - MarketWatch (press release)
Promedior Appoints Suzanne L. Bruhn, Ph.D., as President and Chief Executive ... MarketWatch (press release) Dr. Bruhn takes on the role of CEO at a time when Promedior is rapidly advancing its product candidates in human clinical trials for diseases involving fibrosis, including idiopathic pulmonary fibrosis (IPF), myelofibrosis, and retinal diseases.
FibroGen Expands Clinical Study Based on Preliminary Data Indicating ... - MarketWatch (press release)
FibroGen Expands Clinical Study Based on Preliminary Data Indicating ... MarketWatch (press release) ... expansion of an ongoing open-label Phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF).
Taylor hopes for new lungs, new life - Richmond County Daily Journal
Taylor hopes for new lungs, new life Richmond County Daily Journal Seven years ago, John Taylor of Cordova was diagnosed with idiopathic pulmonary fibrosis. ?I had never heard of that, didn't understand what it meant,? said Taylor. Idiopathic pulmonary fibrosis is scarring or thickening of the lungs without a known ...
Bettendorf football coaching icon Habenicht dies at 77 - Indianapolis Star
Pulmonary fibrosis hasn't stopped cyclist's pedals InsideHalton.com When Rob Alexander-Carew was diagnosed with idiopathic pulmonary fibrosis, a degenerative lung disease, last July, he refused to give up his exercise routine of indoor cycling. The 39-year-old Oakville resident said that he was determined to struggle ...
Stony Brook, NYU in deal with drug firm - Chicago Tribune
Stony Brook, NYU in deal with drug firm Chicago Tribune It calls for the New Brunswick, NJ, company to work with researchers from the schools on an inhalable treatment for the condition, idiopathic pulmonary fibrosis. The disease affects about 200000 Americans each year. It's caused by scar tissue in the ...
What our clients and candidates are saying about us: Thanks a lot for all your help! I will never forget you as you not only helped me but instilled confidence in me to get my first break in this country. - Rajashree
The #1 Resource for professionals in the Pharmaceutical Advertising, Medical Communications, Healthcare Public Relations, Pharmaceutical Industry, and Biotechnology fields since 1988.